Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study, Evaluating HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025

NCT02095210 is registered in ClinicalTrials.gov with Dorte Nielsen as lead sponsor.

NCT NCT02095210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02095210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study, Evaluating HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025
Lead sponsor
Dorte Nielsen
Phase
Phase 1
Overall status
Terminated
Start date
August 31, 2011
Completion date
August 13, 2014
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2-positive breast cancer